Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.
Holders of 5% or more of CAMP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Camp4 Therapeutics Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Janus Henderson Group PLC | 13G | 12.20%6.31M shares | New | Jan 8, 20261 filing | Jan 8, 2026 | SEC |
| Coastlands Capital LP | 13G/A | 9.99%4.89M shares | −0.01 ppfrom 10.00% | Sep 16, 20252 filings | Dec 11, 2025 | SEC |
| 5AM Ventures VI, L.P. | 13D/A | 9.90%6.38M shares | 0.00 ppfrom 9.90% | Sep 11, 20253 filings | Aug 31, 2026 | SEC |
| FMR LLC | 13G/A | 9.50%4.92M shares | +2.80 ppfrom 6.70% | Oct 7, 20253 filings | Feb 5, 2026 | SEC |
| Vivo Opportunity Fund Holdings, L.P. | 13G/A | 7.40%3.86M shares | −0.20 ppfrom 7.60% | Sep 17, 20252 filings | Feb 13, 2026 | SEC |
| Polaris Management Co. VII, L.L.C. | 13D/A | 6.30%3.93M shares | −2.10 ppfrom 8.40% | Sep 11, 20252 filings | Aug 19, 2026 | SEC |
| Trails Edge Capital Partners, LP | 13G | 6.00%3.79M shares | New | Aug 10, 20261 filing | Aug 10, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
23 Schedule 13D and 13G filings on Camp4 Therapeutics Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 31, 20265:06 PM ET | 5AM Ventures VI, L.P.and 7 others | 13D/A | 9.90%6.38M shares | 0.00 ppfrom 9.90% | Aug 27, 2026 | SEC |
| Aug 19, 20267:03 PM ET | Polaris Management Co. VII, L.L.C.and 7 others | 13D/A | 6.30%3.93M shares | −2.10 ppfrom 8.40% | Aug 13, 2026 | SEC |
| Aug 14, 20266:00 AM ET | Balyasny Asset Management LLCand 4 others | 13G/A | 4.99%2.59M shares | −0.08 ppfrom 5.07%Below 5% | Jun 30, 2026 | SEC |
| Aug 10, 20265:30 PM ET | Trails Edge Capital Partners, LPand 2 others | 13G | 6.00%3.79M shares | New | Aug 3, 2026 | SEC |
| Aug 5, 20265:43 PM ET | 5AM Ventures VI, L.P.and 7 others | 13D/A | 9.90%6.31M shares | −2.60 ppfrom 12.50% | Aug 3, 2026 | SEC |
| May 15, 20266:29 AM ET | Balyasny Asset Management LLCand 4 others | 13G | 5.07%2.63M shares | New | Mar 31, 2026 | SEC |
| Mar 11, 20265:57 PM ET | Enavate Sciences GP, LLCand 1 other | 13D/A | 4.80%2.50M shares | −1.20 ppfrom 6.00%Below 5% | Mar 9, 2026 | SEC |
| Feb 13, 20266:11 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G/A | 7.40%3.86M shares | −0.20 ppfrom 7.60% | Dec 31, 2025 | SEC |
| Feb 5, 20261:20 PM ET | FMR LLCand 1 other | 13G/A | 9.50%4.92M shares | +2.80 ppfrom 6.70% | Dec 31, 2025 | SEC |
| Jan 8, 202612:15 PM ET | Janus Henderson Group PLC | 13G | 12.20%6.31M shares | New | Dec 31, 2025 | SEC |
| Dec 23, 20255:58 PM ET | Enavate Sciences GP, LLCand 1 other | 13D/A | 6.00%3.13M shares | −2.10 ppfrom 8.10% | Dec 19, 2025 | SEC |
| Dec 11, 202512:28 PM ET | Coastlands Capital LPand 4 others | 13G/A | 9.99%4.89M shares | −0.01 ppfrom 10.00% | Sep 10, 2025 | SEC |
| Nov 14, 20256:23 PM ET | AH Bio Fund I, L.P.and 5 others | 13G/A | 4.50%2.13M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20254:49 PM ET | Northpond Ventures II, LPand 6 others | 13G/A | 4.80%2.24M shares | –Below 5% | Sep 30, 2025 | SEC |
| Nov 7, 202511:13 AM ET | FMR LLCand 1 other | 13G/A | 6.70%3.15M shares | −8.30 ppfrom 15.00% | Oct 31, 2025 | SEC |
| Oct 7, 20253:49 PM ET | FMR LLCand 1 other | 13G | 15.00%3.02M shares | New | Sep 30, 2025 | SEC |
| Oct 1, 202511:30 AM ET | HarbourVest Partners LLCand 3 others | 13G/A | 2.70%1.27M shares | −3.60 ppfrom 6.30%Below 5% | Sep 30, 2025 | SEC |
| Sep 17, 20256:31 PM ET | Vivo Opportunity Fund Holdings, L.P.and 3 others | 13G | 7.60%3.56M shares | New | Sep 11, 2025 | SEC |
| Sep 16, 20254:41 PM ET | Coastlands Capital LPand 4 others | 13G | 10.00%4.89M shares | New | Sep 10, 2025 | SEC |
| Sep 15, 20257:08 PM ET | Enavate Sciences GP, LLCand 1 other | 13D/A | 8.10%3.79M shares | – | Sep 11, 2025 | SEC |
| Sep 11, 20255:05 PM ET | Polaris Management Co. VII, L.L.C.and 7 others | 13D/A | 8.40%3.93M shares | – | Sep 9, 2025 | SEC |
| Sep 11, 20254:25 PM ET | 5AM Ventures VI, L.P.and 7 others | 13D/A | 12.50%5.87M shares | – | Sep 9, 2025 | SEC |
| May 14, 20251:45 PM ET | HarbourVest Partners LLCand 3 others | 13G | 6.30%1.27M shares | New | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Camp4 Therapeutics Corp shares.
No Form 144 notices for Camp4 Therapeutics Corp are on file.